Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cyclerion Therapeutics, Inc. | President and Chief Executive Officer, Director | Common Stock | 100K | $341K | $3.40 | Jan 1, 2024 | Direct |
Cyclerion Therapeutics, Inc. | President and Chief Executive Officer, Director | Stock Option (Right to Buy) | 55.8K | Aug 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CYCN | Cyclerion Therapeutics, Inc. | Aug 5, 2024 | 1 | $0 | 4 | Aug 7, 2024 | President and Chief Executive Officer, Director |
CYCN | Cyclerion Therapeutics, Inc. | Jan 1, 2024 | 1 | $0 | 4 | Jan 26, 2024 | President |
CYCN | Cyclerion Therapeutics, Inc. | Dec 1, 2023 | 0 | $0 | 3/A | Dec 7, 2023 | President |